J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 69 (1988), 2101-2107; DOI 10.1099/0022-1317-69-8-2101
© 1988 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henchal, E. A.
Right arrow Articles by Schlesinger, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henchal, E. A.
Right arrow Articles by Schlesinger, J. J.
Agricola
Right arrow Articles by Henchal, E. A.
Right arrow Articles by Schlesinger, J. J.

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

E. A. Henchal1,{dagger}, L. S. Henchal1 and J. J. Schlesinger2

1 Department of Virology, U.S. Army Medical Component, Armed Forces Research Institute of the Medical Sciences, 315/6 Rajavithi Road, Bangkok 10400, Thailand
and2 Department of Medicine, Rochester General Hospital and the University of Rochester School of Medicine and Dentistry, Rochester, New York 14621, U.S.A.

Non-neutralizing, serotype-specific anti-NS1 monoclonal antibodies partially protected passively immunized mice from lethal dengue 2 virus intracerebral challenge. There was no apparent correlation between complement-fixing activity and protective capacity among individual anti-NS1 monoclonal antibodies. Immunization with specific combinations of non-protective or partially protective antibodies resulted in prolonged survival or reduced mortality. Solid protection, equal to that achieved after immunization with neutralizing polyclonal antibody, was achieved only with an antibody pair which individually fixed complement to high titre with homologous virus. Some groups of mice had increased morbidity after immunization with combinations of protective monoclonal antibodies that bind to overlapping epitopes. These results may affect the design of recombinant dengue vaccines which may require the inclusion of serotype-specific antigenic domains.

Keywords: dengue 2 virus, flaviviruses, passive protection

{dagger} Present address: Department of Virus Diseases, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100, U.S.A.

Received 16 December 1987; accepted 25 March 1988.


This article has been cited by other articles:


Home page
J. Virol.Home page
C.-Y. Lai, W.-Y. Tsai, S.-R. Lin, C.-L. Kao, H.-P. Hu, C.-C. King, H.-C. Wu, G.-J. Chang, and W.-K. Wang
Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II
J. Virol., July 1, 2008; 82(13): 6631 - 6643.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. Clyde, J. L. Kyle, and E. Harris
Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis
J. Virol., December 1, 2006; 80(23): 11418 - 11431.
[Full Text] [PDF]


Home page
J. Virol.Home page
M. Simmons, K. R. Porter, C. G. Hayes, D. W. Vaughn, and R. Putnak
Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques
J. Virol., October 1, 2006; 80(19): 9577 - 9585.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. Hangartner, R. M. Zellweger, M. Giobbi, J. Weber, B. Eschli, K. D. McCoy, N. Harris, M. Recher, R. M. Zinkernagel, and H. Hengartner
Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread
J. Exp. Med., August 7, 2006; 203(8): 2033 - 2042.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. M. Chung, G. E. Nybakken, B. S. Thompson, M. J. Engle, A. Marri, D. H. Fremont, and M. S. Diamond
Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc {gamma} Receptor-Dependent and -Independent Mechanisms
J. Virol., February 1, 2006; 80(3): 1340 - 1351.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Mehlhop, K. Whitby, T. Oliphant, A. Marri, M. Engle, and M. S. Diamond
Complement Activation Is Required for Induction of a Protective Antibody Response against West Nile Virus Infection
J. Virol., June 15, 2005; 79(12): 7466 - 7477.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. Shrestha and M. S. Diamond
Role of CD8+ T Cells in Control of West Nile Virus Infection
J. Virol., August 1, 2004; 78(15): 8312 - 8321.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Men, T. Yamashiro, A. P. Goncalvez, C. Wernly, D. J. Schofield, S. U. Emerson, R. H. Purcell, and C.-J. Lai
Identification of Chimpanzee Fab Fragments by Repertoire Cloning and Production of a Full-Length Humanized Immunoglobulin G1 Antibody That Is Highly Efficient for Neutralization of Dengue Type 4 Virus
J. Virol., May 1, 2004; 78(9): 4665 - 4674.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Shresta, J. L. Kyle, H. M. Snider, M. Basavapatna, P. R. Beatty, and E. Harris
Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical
J. Virol., March 15, 2004; 78(6): 2701 - 2710.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. J. Engle and M. S. Diamond
Antibody Prophylaxis and Therapy against West Nile Virus Infection in Wild-Type and Immunodeficient Mice
J. Virol., December 15, 2003; 77(24): 12941 - 12949.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. S. Diamond, E. M. Sitati, L. D. Friend, S. Higgs, B. Shrestha, and M. Engle
A Critical Role for Induced IgM in the Protection against West Nile Virus Infection
J. Exp. Med., December 15, 2003; 198(12): 1853 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
R. EDELMAN, S. S. WASSERMAN, S. A. BODISON, R. J. PUTNAK, K. H. ECKELS, D. TANG, N. KANESA-THASAN, D. W. VAUGHN, B. L. INNIS, and W. SUN
PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE
Am J Trop Med Hyg, December 1, 2003; 69(90060): 48 - 60.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
P. R. Young, P. A. Hilditch, C. Bletchly, and W. Halloran
An Antigen Capture Enzyme-Linked Immunosorbent Assay Reveals High Levels of the Dengue Virus Protein NS1 in the Sera of Infected Patients
J. Clin. Microbiol., March 1, 2000; 38(3): 1053 - 1057.
[Abstract] [Full Text]


Home page
J. Virol.Home page
E. Konishi, M. Yamaoka, Khin-Sane-Win, I. Kurane, K. Takada, and P. W. Mason
The Anamnestic Neutralizing Antibody Response Is Critical for Protection of Mice from Challenge following Vaccination with a Plasmid Encoding the Japanese Encephalitis Virus Premembrane and Envelope Genes
J. Virol., July 1, 1999; 73(7): 5527 - 5534.
[Abstract] [Full Text]


Home page
J. Virol.Home page
E. Konishi, M. Yamaoka, Khin-Sane-Win, I. Kurane, and P. W. Mason
Induction of Protective Immunity against Japanese Encephalitis in Mice by Immunization with a Plasmid Encoding Japanese Encephalitis Virus Premembrane and Envelope Genes
J. Virol., June 1, 1998; 72(6): 4925 - 4930.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1988 by the Society for General Microbiology.